AMPATH Lab: Blood Tests For Coagulation Disorders

Blood Tests for Coagulation Disorders

Blood tests are a crucial aspect of diagnosing coagulation disorders. Coagulation disorders refer to inherited or acquired conditions where the blood fails to clot normally. Blood tests are essential for diagnosing any blood-related disorders, including coagulation disorders. These tests help healthcare professionals to determine whether blood cells are healthy, the blood is clotting appropriately, and whether the blood can regulate clotting efficiently.

Complete blood count (CBC)
A complete blood count is a routine blood test that analyses the composition and concentration of different components of the blood. The red blood cells, white blood cells, and platelets are all quantified in a CBC test. Changes observed in the platelet count may indicate a coagulation disorder. Blood platelets are responsible for blood clotting. If an individual's platelet count falls outside the "normal range," it can be a sign that the body is struggling to form blood clots efficiently.

Prothrombin Time (PT)
Prothrombin time measures the blood's ability to clot. PT is used to evaluate the effectiveness of medication given to individuals with blood clots. It is also used in the diagnosis of liver disorders. PT measures the level of prothrombin present in the blood. It is a crucial component in the formation of blood clots. If the prothrombin levels are low, the blood will not clot properly. On the other hand, if the prothrombin levels are high, the individual is at risk of developing blood clots.

Activated Partial Thromboplastin Time (APTT)
The activated partial thromboplastin time test assesses the functionality of the intrinsic coagulation pathway. The intrinsic coagulation pathway begins when blood contacts a foreign substance, such as a cut, and is essential in the formation of blood clots. A prolonged APTT indicates the presence of an intrinsic coagulation pathway problem.

Thrombin Time (TT)
Thrombin time measures how long a blood clot takes to form after thrombin, a clotting factor, is added to a blood sample. TT is used to ascertain fibrinogen's capacity to interact with thrombin and form a stable clot. A prolonged TT indicates a low level of fibrinogen, which can impair blood clotting.

Conclusion:
Blood tests are essential in diagnosing individuals with coagulation disorders. Several blood tests can be used in diagnosing coagulation disorders, including complete blood counts, prothrombin time, activated partial thromboplastin time, and thrombin time. It is essential to consult a healthcare professional if you experience any unusual symptoms to determine whether you have a coagulation disorder. A proper diagnosis, coupled with proper treatment, can help individuals with coagulation disorders lead a healthy life.